Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serotonin and brain function: a tale of two receptors
RL Carhart-Harris, DJ Nutt
Journal of Psychopharmacology (2017) Vol. 31, Iss. 9, pp. 1091-1120
Open Access | Times Cited: 597

Showing 1-25 of 597 citing articles:

REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics
Robin Carhart‐Harris, Karl Friston
Pharmacological Reviews (2019) Vol. 71, Iss. 3, pp. 316-344
Open Access | Times Cited: 784
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
Robin Carhart‐Harris, Mark Bolstridge, Camilla Day, et al.
Psychopharmacology (2017) Vol. 235, Iss. 2, pp. 399-408
Open Access | Times Cited: 774
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
Leor Roseman, David Nutt, Robin Carhart‐Harris
Frontiers in Pharmacology (2018) Vol. 8
Open Access | Times Cited: 646
Psychedelics and the essential importance of context
Robin Carhart‐Harris, Leor Roseman, Eline Haijen, et al.
Journal of Psychopharmacology (2018) Vol. 32, Iss. 7, pp. 725-731
Closed Access | Times Cited: 511
The entropic brain - revisited
Robin Carhart‐Harris
Neuropharmacology (2018) Vol. 142, pp. 167-178
Closed Access | Times Cited: 434
Increased global integration in the brain after psilocybin therapy for depression
Richard E. Daws, Christopher Timmermann, Bruna Giribaldi, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 844-851
Open Access | Times Cited: 312
Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer
Gabrielle Agin-Liebes, Tara C. Malone, Matthew M. Yalch, et al.
Journal of Psychopharmacology (2020) Vol. 34, Iss. 2, pp. 155-166
Closed Access | Times Cited: 266
Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies
Kristoffer A. A. Andersen, Robin Carhart‐Harris, David Nutt, et al.
Acta Psychiatrica Scandinavica (2020) Vol. 143, Iss. 2, pp. 101-118
Closed Access | Times Cited: 259
Psychedelic Psychiatry’s Brave New World
David Nutt, David Erritzøe, Robin Carhart‐Harris
Cell (2020) Vol. 181, Iss. 1, pp. 24-28
Open Access | Times Cited: 257
Psychedelics and connectedness
Robin Carhart‐Harris, David Erritzøe, Eline Haijen, et al.
Psychopharmacology (2017) Vol. 235, Iss. 2, pp. 547-550
Closed Access | Times Cited: 237
Effects of psilocybin therapy on personality structure
David Erritzøe, Leor Roseman, Matthew M. Nour, et al.
Acta Psychiatrica Scandinavica (2018) Vol. 138, Iss. 5, pp. 368-378
Open Access | Times Cited: 225
Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders
Simone B. Sartori, Nicolas Singewald
Pharmacology & Therapeutics (2019) Vol. 204, pp. 107402-107402
Open Access | Times Cited: 206
Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin
Natasha L. Mason, Kim P. C. Kuypers, Felix Müller, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 12, pp. 2003-2011
Open Access | Times Cited: 205
Whole-Brain Multimodal Neuroimaging Model Using Serotonin Receptor Maps Explains Non-linear Functional Effects of LSD
Gustavo Deco, Josephine Cruzat, Joana Cabral, et al.
Current Biology (2018) Vol. 28, Iss. 19, pp. 3065-3074.e6
Open Access | Times Cited: 202
DMT Models the Near-Death Experience
Christopher Timmermann, Leor Roseman, L. Williams, et al.
Frontiers in Psychology (2018) Vol. 9
Open Access | Times Cited: 191
The Current Status of Psychedelics in Psychiatry
David Nutt, Robin Carhart‐Harris
JAMA Psychiatry (2020) Vol. 78, Iss. 2, pp. 121-121
Closed Access | Times Cited: 189
Towards an understanding of psychedelic-induced neuroplasticity
Abigail E. Calder, Gregor Hasler
Neuropsychopharmacology (2022) Vol. 48, Iss. 1, pp. 104-112
Open Access | Times Cited: 183
Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression
Leor Roseman, Lysia Demetriou, Matthew B. Wall, et al.
Neuropharmacology (2017) Vol. 142, pp. 263-269
Open Access | Times Cited: 180
The Meaning-Enhancing Properties of Psychedelics and Their Mediator Role in Psychedelic Therapy, Spirituality, and Creativity
Ido Hartogsohn
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 179
Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics
Cato M. H. de Vos, Natasha L. Mason, Kim P. C. Kuypers
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 176
Microdosing psychedelics: More questions than answers? An overview and suggestions for future research
Kim P. C. Kuypers, Livia Ng, David Erritzøe, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 9, pp. 1039-1057
Open Access | Times Cited: 172
Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics
Lily R. Aleksandrova, Anthony G. Phillips
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 11, pp. 929-942
Closed Access | Times Cited: 166
Unifying Theories of Psychedelic Drug Effects
Link Ray Swanson
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 165
The psychedelic renaissance and the limitations of a White-dominant medical framework: A call for indigenous and ethnic minority inclusion
Jamilah R. George, Timothy I. Michaels, Jae Sevelius, et al.
Journal of Psychedelic Studies (2019) Vol. 4, Iss. 1, pp. 4-15
Open Access | Times Cited: 160
Antidepressive Mechanisms of Probiotics and Their Therapeutic Potential
Shin Jie Yong, Tommy Tong, Jactty Chew, et al.
Frontiers in Neuroscience (2020) Vol. 13
Open Access | Times Cited: 159
Page 1 - Next Page

Scroll to top